scholarly journals Prostate Capsule

2020 ◽  
Author(s):  
Keyword(s):  
2019 ◽  
Vol 20 (3) ◽  
pp. 27-36 ◽  
Author(s):  
Angela U. Pathmanathan ◽  
Maria A. Schmidt ◽  
Douglas H. Brand ◽  
Evanthia Kousi ◽  
Nicholas J. As ◽  
...  

1997 ◽  
Vol 64 (3) ◽  
pp. 291-295
Author(s):  
G. Ferrari ◽  
G. Castagnetti ◽  
A. Dotti ◽  
A.M. Cesinaro ◽  
C. De Gaetani ◽  
...  

The incidence of prostate cancer is rising and great attention has to be paid when staging this malignant disease in order to avoid unnecessary surgery. Techniques for diagnosis by biopsy are by now standardised, but clinical staging has a high percentage of understaging (over 43%). Multiple sextant prostate biopsies involving the seminal vesicles and prostate capsule seem to be basic for current staging. These data associated with PSA, volume of the cancer and the Gleason score are the most objective and reliable parameters for correct clinical evaluation of prostate cancer.


2008 ◽  
Author(s):  
Liyang Wei ◽  
Ramkrishnan Narayanan ◽  
Dinesh Kumar ◽  
Aaron Fenster ◽  
Albaha Barqawi ◽  
...  
Keyword(s):  

2015 ◽  
Vol 33 (7_suppl) ◽  
pp. 52-52
Author(s):  
Anna Mary Brown ◽  
Sandeep Sankineni ◽  
Arvin Koruthu George ◽  
Soroush Rais-Bahrami ◽  
Bradford J. Wood ◽  
...  

52 Background: The subcapsular region is often under-sampled by standard 12-core transrectal ultrasound (TRUS) prostate biopsy. We retrospectively evaluated multi-parametric MRI (mpMRI) features of subcapsular prostate cancers (PCa) and their detection on MRI/TRUS fusion-guided biopsy (FgBx). Methods: All patients referred for 3T mpMRI and subsequent FgBx under an IRB-approved protocol from Jan 2010 to July 2014 were reviewed. Histologically confirmed subcapsular lesions (just inside the prostate capsule with capsular border length >> width) were identified. Impact of the FgBx on clinical management according to current National Comprehensive Cancer Network (NCCN) guidelines was evaluated, with prior status based on outside TRUS biopsy results. Results: Of 992 eligible patients, 33 had subcapsular prostate lesions on mpMRI. In this subpopulation, mean age, PSA, and prostate volume were 63 years (range 52-76), 8.4ng/mL (1.2-63), and 53 mL (12-125). The FgBx, consisting of targeted (TBx) and systematic (SBx) portions, confirmed PCa in 24 of 33 patients. Five cancers (21%) were only detected by TBx. The remaining 19 were diagnosed on both TBx and SBx, but in 5 of these 19 (26%), higher Gleason scores were found on TBx cores. The FgBx results more accurately classified patients’ NCCN risk scores, with 17 prior unknown or low risk PCa upgraded to higher risk scores (Table). Conclusions: Subcapsular lesions on mpMRI are rare but largely malignant. Most are found on 12-core SBx, but ~20% require TBx for diagnosis, and TBx more accurately grades >25% of the lesions. The FgBx may improve clinical management of patients with subcapsular PCa, since more aggressive cancer was found in 17 of 24 patients. [Table: see text] [Table: see text] [Table: see text]


2019 ◽  
Vol 18 (12) ◽  
pp. e3636-e3637
Author(s):  
George Managadze ◽  
George Sharashenidze ◽  
Irakli Surmanidze ◽  
Ambrosi Pertia

2006 ◽  
Vol 175 (4S) ◽  
pp. 397-397 ◽  
Author(s):  
Alon Z. Weizer ◽  
Rajal B. Shah ◽  
Scott B. Gilbert ◽  
Stephanie Daignault ◽  
Cheryl T. Lee ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document